Legal Opinion
Abbott Laboratories v. Mylan Pharmaceuticals, Inc.
District Court of Appeal of Florida
Decided June 22, 2009No. 1D08-0602PublishedCited by 9 opinions
1Opinion of the CourtVan Nortwick, J.
Abbott Laboratories (Abbott), the manufacturer of a levothyroxine sodium (LS) drug product, Synthroid®, appeals a summary final order of an administrative law judge (ALJ) in a rule challenge proceeding brought by Mylan Pharmaceuticals, Inc. (Mylan), appellee, the manufacturer of a competing generic drug. In the summary final order, the ALJ ruled that Florida Administrative Code Rule 64B16-27.500(6), which was part of the negative drug formulary (NDF) rule established pursuant to section 465.025(6), Florida Statutes (2007), and which listed LS on the NDF, was invalid on the grounds that it…
2Cases cited26 opinions
- Forsythe v. Longboat Key Beach ErosionSupreme Court of Florida · 1992
- Florida Hosp. Waterman, Inc. v. BusterSupreme Court of Florida · 2008
- Daniels v. Florida Parole & Probation Comm'nDistrict Court of Appeal of Florida · 1981
- FLORIDA DEPT., OF OFFENDER REHAB. v. JerryDistrict Court of Appeal of Florida · 1978
- Department of Legal Affairs v. RogersSupreme Court of Florida · 1976
21 more not listed; retrieve them via the Exa API.
3Cited by9 opinions
- Iezzi Family Limited Partnership v. Edgewater Beach Owners Association, etc.District Court of Appeal of Florida · 2018
- Delgado v. Agency for Health Care Admin.District Court of Appeal of Florida · 2018
- Gadsden Jai Alai, Inc. v. State, Department of Business & Professional Regulation, Division of Pari-Mutuel WageringDistrict Court of Appeal of Florida · 2010
- J.S. v. C.M.District Court of Appeal of Florida · 2012
- JFK Medical Center Limited etc. v. Shands Jacksonville Medical Center etc.District Court of Appeal of Florida · 2018
4 more not listed; retrieve them via the Exa API.